Finland: Health System Review.


Journal

Health systems in transition
ISSN: 1817-6127
Titre abrégé: Health Syst Transit
Pays: Denmark
ID NLM: 101492637

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 10 10 2019
pubmed: 10 10 2019
medline: 22 1 2020
Statut: ppublish

Résumé

This analysis of the Finnish health system reviews developments in its organization and governance, financing, provision of services, health reforms and health system performance. Finland is a welfare state witha high standard of social and living conditions and a low poverty rate. Its health system has a highly decentralized administration, multiple funding sources, and three provision channels for statutory services in first-contact care: the municipal system, the national health insurance system, and occupational health care. The core health system is organized by the municipalities (i.e. local authorities) which are responsible for financing primary and specialized care. Health financing arrangements are fragmented, with municipalities, the health insurance system, employers and households all contributing substantial shares. The health system performs relatively well, as health services are fairly effective, but accessibility may be an issue due to long waiting times and relatively high levels of cost sharing. For over a decade, there has been broad agreement on the need to reform the Finnish health system, but reaching a feasible policy consensus has been challenging.

Identifiants

pubmed: 31596240

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-166

Informations de copyright

World Health Organization 2019 (acting as the host organization for, and secretariat of, the European Observatory on Health Systems and Policies).

Auteurs

Ilmo Keskimaki (I)

Finnish Institute for Health and Welfare and Tampere University.

Liina-Kaisa Tynkkynen (LK)

Tampere University.

Eeva Reissell (E)

Finnish Institute for Health and Welfare.

Meri Koivusalo (M)

Tampere University.

Vesa Syrja (V)

Finnish Institute for Health and Welfare.

Lauri Vuorenkoski (L)

Finnish Medical Association.

Bernd Rechel (B)

European Observatory on Health Systems and Policies.

Marina Karanikolos (M)

European Observatory on Health Systems and Policies.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH